MALVERN, Pa.--(BUSINESS WIRE)--Falcon Consulting Group, Inc., a leading global research quality and compliance company, has changed its name to Advarra Consulting, Inc. The new name reflects the organization’s presence as a wholly owned subsidiary of Advarra, Inc.
Advarra’s proactive, collaborative consulting approach helps research sponsors, CROs and institutions strengthen and grow their research enterprises, helping to maintain quality systems, data integrity and compliance, minimize regulatory risk and protect the safety and welfare of clinical trial participants. With global scale and reach, Advarra Consulting has conducted research compliance projects in more than 60 countries.
“The merger of Chesapeake IRB and Schulman IRB to form Advarra presented a great opportunity to consolidate all of our consulting activities into a comprehensive service offering,” said Randall Hein, President of Advarra Consulting. “The exceptional reputation and capabilities provided by Falcon Consulting in quality assurance consulting, regulatory compliance and full GxP support, combined with human research protection (HRP) and IRB consulting services, allow us to offer our clients seamless capabilities across the research compliance spectrum.”
Advarra Consulting will continue to headquarter from its Malvern offices. There will be no changes to clients’ regular contacts, assigned program leads or business development representatives as a result of the name change. “We greatly look forward to sharing our new brand and expanded capabilities with our clients,” said Hein.
Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its innovative technology and global consulting expertise put research participants first, ensuring the highest standards of research review to meet complex human research protection oversight requirements. Advarra supports all phases of research across multiple therapeutic areas. For more information, visit advarra.com.